sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

North America Rare Neurological Disease Treatment Market Scope And Analysis

  • Report Code : TIPRE00010245
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 139
Buy Now

North America Rare Neurological Disease Treatment Market Analysis and Scope (2020 to 2027)

Buy Now

North America Rare Neurological Disease Treatment Market Report North America Rare Neurological Disease Treatment Market Size and Share North America Rare Neurological Disease Treatment Market Scope and Analysis

North America Rare Neurological Disease Treatment Market Report Scope

Report Attribute Details
Market size in 2019 US$ 3,184.10 Million
Market Size by 2027 US$ 6,113.29 Million
Global CAGR (2019 - 2027) 8.7%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Indication
  • Narcolepsy
  • Amyotrophic Lateral Sclerosis
  • Alzheimer's Disease
  • Multiple Sclerosis
  • Spinal Muscular Atrophy
  • Duchenne Muscular Dystrophy
  • Other Indication
By Drug Type
  • Organic Compounds
  • Biologics
By Distribution Channel
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
By Mode of Administration
  • Oral
  • Injectables
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Allergan plc
  • Bayer AG
  • GlaxoSmithKline plc
  • Johnson Johnson Services Inc
  • Merck Co Inc
  • Novartis AG
  • Pfizer Inc
  • Sanofi
  • Teva Pharmaceutical Industries Ltd